Metal-containing complexes have taken up center stage in the search for new cancer drugs that are as free of side effects as possible. In the journal Angewandte Chemie, a research team has now described how a very low dose of a rhenium metal complex interferes with cellular metabolism to such an extent that it kills ovarian cancer cells.
Click here for original story, Low dose of a rhenium metal complex interferes with cellular metabolism to kill ovarian cancer cells
Source: Phys.org